Our pharma-focused compliance partner was restricted by a legacy desktop tool that hindered global scalability. This outdated infrastructure created several critical bottlenecks for life sciences teams:
Legacy desktop tools lack global scalability and accessibility.
Fragmented DevOps practices result in severe CI/CD bottlenecks.
High technical debt increases maintenance costs and system lag.
Infrastructure inefficiencies prevent meeting strict SOC2 and HIPAA standards.
Lack of centralized observability obscures platform performance metrics.
Solution Provided
Icanio Technologies architected a Cloud-Native Azure SaaS Ecosystem, migrating the core logic to a microservices architecture while automating the entire delivery pipeline. The solutions include:
Strategic roadmap for full DevOps and infrastructure modernization.
Automated CI/CD pipelines using Azure DevOps and Repos.
Containerized workload orchestration via Azure Kubernetes Service (AKS).
Multi-tenant microservices architecture for dynamic cloud scalability.
Security hardening using Azure Security Center and DDoS Protection.
Infrastructure as Code (IaC) for HIPAA and GDPR compliance.